Jesse Damsker

Person

Washington, DC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Aqueous oral pharmaceutical suspension compositions
- Patent number 12,201,639
- Issue date Jan 21, 2025
- ReveraGen BioPharma, Inc.
- John McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-κβ for treatment of disease
- Patent number 11,690,853
- Issue date Jul 4, 2023
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acid addition salts, compositions, and methods of treating
- Patent number 11,661,409
- Issue date May 30, 2023
- Pioneura Corporation
- Harris A. Gelbard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acid addition salts, compositions, and methods of treating thereof
- Patent number 11,479,541
- Issue date Oct 25, 2022
- Pioneura Corporation
- Harris A. Gelbard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aqueous oral pharmaceutical suspension compositions
- Patent number 11,471,471
- Issue date Oct 18, 2022
- ReveraGen BioPharma, Inc.
- John McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aqueous oral pharmaceutical suspension compositions
- Patent number 11,382,922
- Issue date Jul 12, 2022
- ReveraGen BioPharma, Inc.
- John McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-kappa beta for treatment of d...
- Patent number 10,799,514
- Issue date Oct 13, 2020
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-κβ for treatment of disease
- Patent number 10,464,967
- Issue date Nov 5, 2019
- ReveraGen BioPharma, Inc.
- John M. McCall
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ACID ADDITION SALTS, COMPOSITIONS, AND METHODS OF TREATING THEREOF
- Publication number 20240376071
- Publication date Nov 14, 2024
- Pioneura Corporation
- Harris A. GELBARD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20240307411
- Publication date Sep 19, 2024
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NF-kB-MEDIATED DISEASE
- Publication number 20240299416
- Publication date Sep 12, 2024
- Reveragen Biopharma, Inc.
- Jesse DAMSKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPOPLASIA
- Publication number 20240226117
- Publication date Jul 11, 2024
- Reveragen Biopharma, Inc.
- Eric Hoffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NF-KB-MEDIATED DISEASE
- Publication number 20240139210
- Publication date May 2, 2024
- Reveragen Biopharma, Inc.
- Jesse DAMSKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS
- Publication number 20230027370
- Publication date Jan 26, 2023
- Reveragen Biopharma, Inc.
- John MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF VAMOROLONE
- Publication number 20230002439
- Publication date Jan 5, 2023
- Reveragen Biopharma, Inc.
- John MCCALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20220324902
- Publication date Oct 13, 2022
- Reveragen Biopharma, Inc.
- John M. MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS
- Publication number 20220193094
- Publication date Jun 23, 2022
- John MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NF-KB-MEDIATED DISEASE
- Publication number 20220184098
- Publication date Jun 16, 2022
- Reveragen Biopharma, Inc.
- Jesse DAMSKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20210046089
- Publication date Feb 18, 2021
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS
- Publication number 20200281942
- Publication date Sep 10, 2020
- Reveragen Biopharma, Inc.
- John MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20200148717
- Publication date May 14, 2020
- Reveragen Biopharma, Inc.
- John M. MCCALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20160375037
- Publication date Dec 29, 2016
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20150011519
- Publication date Jan 8, 2015
- Reveragen Biopharma, Inc.
- John M. McCall
- C07 - ORGANIC CHEMISTRY

Jesse Damsker

Person

Patents Grantslast 30 patents

Aqueous oral pharmaceutical suspension compositions

Non-hormonal steroid modulators of NF-κβ for treatment of disease

Acid addition salts, compositions, and methods of treating

Acid addition salts, compositions, and methods of treating thereof

Aqueous oral pharmaceutical suspension compositions

Aqueous oral pharmaceutical suspension compositions

Non-hormonal steroid modulators of NF-kappa beta for treatment of d...

Non-hormonal steroid modulators of NF-κβ for treatment of disease

Patents Applicationslast 30 patents

ACID ADDITION SALTS, COMPOSITIONS, AND METHODS OF TREATING THEREOF

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

TREATMENT OF NF-kB-MEDIATED DISEASE

TREATMENT OF CONGENITAL ADRENAL HYPOPLASIA

TREATMENT OF NF-KB-MEDIATED DISEASE

AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS

CRYSTALLINE FORMS OF VAMOROLONE

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS

TREATMENT OF NF-KB-MEDIATED DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...